2
31/12/2023
2023-12-31
false
false
false
false
false
false
false
false
false
false
true
false
false
true
false
false
false
false
false
true
false
No description of principal activities is disclosed
2023-01-01
Sage Accounts Production 21.0 - FRS102_2021
xbrli:pure
xbrli:shares
iso4217:GBP
11094679
2023-01-01
2023-12-31
11094679
2023-12-31
11094679
2022-12-31
11094679
2022-01-01
2022-12-31
11094679
2022-12-31
11094679
2021-12-31
11094679
core:FurnitureFittingsToolsEquipment
2023-01-01
2023-12-31
11094679
bus:RegisteredOffice
2023-01-01
2023-12-31
11094679
bus:LeadAgentIfApplicable
2023-01-01
2023-12-31
11094679
bus:Director1
2023-01-01
2023-12-31
11094679
bus:Director2
2023-01-01
2023-12-31
11094679
core:FurnitureFittingsToolsEquipment
2022-12-31
11094679
core:FurnitureFittingsToolsEquipment
2023-12-31
11094679
core:RetainedEarningsAccumulatedLosses
2022-01-01
2022-12-31
11094679
core:RetainedEarningsAccumulatedLosses
2023-01-01
2023-12-31
11094679
core:WithinOneYear
2023-12-31
11094679
core:WithinOneYear
2022-12-31
11094679
core:ShareCapital
2023-12-31
11094679
core:ShareCapital
2022-12-31
11094679
core:RetainedEarningsAccumulatedLosses
2023-12-31
11094679
core:RetainedEarningsAccumulatedLosses
2022-12-31
11094679
core:ShareCapital
2021-12-31
11094679
core:RetainedEarningsAccumulatedLosses
2021-12-31
11094679
core:FurnitureFittingsToolsEquipment
2022-12-31
11094679
bus:Director1
2022-12-31
11094679
bus:Director1
2023-12-31
11094679
bus:Director1
2021-12-31
11094679
bus:Director1
2022-12-31
11094679
bus:Director1
2022-01-01
2022-12-31
11094679
bus:SmallEntities
2023-01-01
2023-12-31
11094679
bus:AuditExemptWithAccountantsReport
2023-01-01
2023-12-31
11094679
bus:FullAccounts
2023-01-01
2023-12-31
11094679
bus:SmallCompaniesRegimeForAccounts
2023-01-01
2023-12-31
11094679
bus:PrivateLimitedCompanyLtd
2023-01-01
2023-12-31
Company registration number:
11094679
INVENTA MEDICAL UK LIMITED
31 December 2023
HEYWOODS
Chartered Accountants
Countrywide House
Knights Way
Shrewsbury
Shropshire
SY1 3AB
INVENTA MEDICAL UK LIMITED
Contents
Directors and other information
Accountants report
Statement of financial position
Statement of changes in equity
Notes to the financial statements
INVENTA MEDICAL UK LIMITED
DIRECTORS AND OTHER INFORMATION
|
|
|
|
Directors |
Mr C J Atkin |
|
|
Mrs V J Atkin |
|
|
|
|
|
|
|
Company number |
11094679 |
|
|
|
|
|
|
|
Registered office |
Countrywide House |
|
|
Knights Way |
|
|
Shrewsbury |
|
|
Shropshire |
|
|
SY1 3AB |
|
|
|
|
|
|
|
Business address |
Booley Cottage |
|
|
Stanton Upon Hine Heath |
|
|
Shropshire |
|
|
SY4 4NB |
|
|
|
|
|
|
|
Accountants |
Heywoods |
|
|
Countrywide House |
|
|
Knights Way |
|
|
Shrewsbury |
|
|
Shropshire |
|
|
SY1 3AB |
|
|
|
INVENTA MEDICAL UK LIMITED
CHARTERED ACCOUNTANTS REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE
UNAUDITED STATUTORY FINANCIAL STATEMENTS OF INVENTA MEDICAL UK LIMITED
YEAR ENDED 31 DECEMBER 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Inventa Medical UK Limited for the year ended 31 December 2023 which comprise the statement of financial position, statement of changes in equity and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the board of directors of Inventa Medical UK Limited, as a body, in accordance with the terms of our engagement letter dated 4 January 2019. Our work has been undertaken solely to prepare for your approval the financial statements of Inventa Medical UK Limited and state those matters that we have agreed to state to the board of directors of Inventa Medical UK Limited as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Inventa Medical UK Limited and its board of directors as a body for our work or for this report.
It is your duty to ensure that Inventa Medical UK Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Inventa Medical UK Limited. You consider that Inventa Medical UK Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Inventa Medical UK Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Heywoods
Chartered Accountants
Countrywide House
Knights Way
Shrewsbury
Shropshire
SY1 3AB
18 March 2024
INVENTA MEDICAL UK LIMITED
STATEMENT OF FINANCIAL POSITION
31 DECEMBER 2023
|
|
|
2023 |
|
|
|
2022 |
|
|
|
|
Note |
£ |
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
|
Fixed assets |
|
|
|
|
|
|
|
|
|
Tangible assets |
|
5 |
5,088 |
|
|
|
5,987 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
5,088 |
|
|
|
5,987 |
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
Debtors |
|
6 |
- |
|
|
|
776 |
|
|
Cash at bank and in hand |
|
|
45 |
|
|
|
60 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
45 |
|
|
|
836 |
|
|
Creditors: amounts falling due |
|
|
|
|
|
|
|
|
|
within one year |
|
7 |
(
2,059) |
|
|
|
(
3,186) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
Net current liabilities |
|
|
|
|
(
2,014) |
|
|
|
(
2,350) |
|
|
|
|
|
_______ |
|
|
|
_______ |
Total assets less current liabilities |
|
|
|
|
3,074 |
|
|
|
3,637 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provisions for liabilities |
|
|
|
|
(
1,137) |
|
|
|
(
1,137) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
|
|
|
_______ |
Net assets |
|
|
|
|
1,937 |
|
|
|
2,500 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
|
|
|
|
Called up share capital |
|
|
|
|
2 |
|
|
|
2 |
Profit and loss account |
|
|
|
|
1,935 |
|
|
|
2,498 |
|
|
|
|
|
_______ |
|
|
|
_______ |
Shareholders funds |
|
|
|
|
1,937 |
|
|
|
2,500 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the
board of directors
and authorised for issue on
11 March 2024
, and are signed on behalf of the board by:
Mr C J Atkin
Director
Company registration number:
11094679
INVENTA MEDICAL UK LIMITED
STATEMENT OF CHANGES IN EQUITY
YEAR ENDED 31 DECEMBER 2023
|
|
Called up share capital |
|
Profit and loss account |
Total |
|
|
|
|
|
|
|
£ |
|
£ |
£ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At 1 January 2022 |
|
2 |
|
3,275 |
3,277 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss for the year |
|
|
|
(
777) |
(
777) |
|
|
|
|
|
|
|
_______ |
|
_______ |
_______ |
|
|
|
|
|
Total comprehensive income for the year |
|
- |
|
(
777) |
(
777) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
|
_______ |
_______ |
|
|
|
|
|
At 31 December 2022 and 1 January 2023 |
|
2 |
|
2,498 |
2,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss for the year |
|
|
|
(
563) |
(
563) |
|
|
|
|
|
|
|
_______ |
|
_______ |
_______ |
|
|
|
|
|
Total comprehensive income for the year |
|
- |
|
(
563) |
(
563) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
|
_______ |
_______ |
|
|
|
|
|
At 31 December 2023 |
|
2 |
|
1,935 |
1,937 |
|
|
|
|
|
|
|
_______ |
|
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVENTA MEDICAL UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 31 DECEMBER 2023
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Countrywide House, Knights Way, Shrewsbury, Shropshire, SY1 3AB.
2.
Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
|
|
|
|
|
|
Fittings fixtures and equipment |
- |
15 % |
reducing balance |
|
|
|
|
|
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
4.
Employee numbers
The average number of persons employed by the company during the year amounted to
2
(2022:
2
).
5.
Tangible assets
|
|
Fixtures, fittings and equipment |
Total |
|
|
|
|
|
|
|
£ |
£ |
|
|
|
|
|
|
Cost |
|
|
|
|
|
|
|
|
At 1 January 2023 and 31 December 2023 |
10,344 |
10,344 |
|
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
|
Depreciation |
|
|
|
|
|
|
|
|
At 1 January 2023 |
4,358 |
4,358 |
|
|
|
|
|
|
Charge for the year |
898 |
898 |
|
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
|
At 31 December 2023 |
5,256 |
5,256 |
|
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
|
Carrying amount |
|
|
|
|
|
|
|
|
At 31 December 2023 |
5,088 |
5,088 |
|
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
|
At 31 December 2022 |
5,986 |
5,986 |
|
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.
Debtors
|
|
|
2023 |
2022 |
|
|
|
£ |
£ |
|
Other debtors |
|
- |
776 |
|
|
|
_______ |
_______ |
|
|
|
|
|
7.
Creditors: amounts falling due within one year
|
|
|
2023 |
2022 |
|
|
|
£ |
£ |
|
Corporation tax |
|
13 |
- |
|
Other creditors |
|
2,046 |
3,186 |
|
|
|
_______ |
_______ |
|
|
|
2,059 |
3,186 |
|
|
|
_______ |
_______ |
|
|
|
|
|
8.
Directors advances, credits and guarantees
|
During the year the directors entered into the following advances and credits with the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the directors |
Amounts repaid |
Balance o/standing |
|
|
|
|
£ |
£ |
£ |
£ |
|
|
|
Mr C J Atkin |
(
2,933) |
- |
1,200 |
(
1,733) |
|
|
|
|
_______ |
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the directors |
Amounts repaid |
Balance o/standing |
|
|
|
|
£ |
£ |
£ |
£ |
|
|
|
Mr C J Atkin |
(
1,954) |
(
979) |
- |
(
2,933) |
|
|
|
|
_______ |
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|